The Global Health Body Sounds Concern Over Critical Lack of Weight-Loss Injections
Less than 10% of patients who could benefit from obesity jabs such as Wegovy are able to get them, states the WHO as it publishes its inaugural advice on the therapies.
With more than one billion individuals worldwide currently living with obesity, it is advocating for more widespread and fairer availability to these injectable treatments.
Per forecasts, over two billion are projected to be living with obesity by 2030 unless action is taken.
"Our new guidance recognises that excess weight is a long-term condition that can be treated with comprehensive and continuous support," stated its chief Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and supply-chain constraints are major barriers to broad availability to the injections that can help people shift considerable body mass, says the organization.
Skinny Jab Scarcity
Even under the current best projected scenario, the manufacturing of GLP-1 therapies could only cover about 100 million people – fewer than 10% of those who need them, according to the health organization.
The recommendation urges governments and firms to increase availability, through approaches such as patent sharing.
Exclusive production rights on the active ingredient – the main ingredient of the drug Wegovy – is scheduled to end in several countries in 2026.
The Way Obesity Drugs Work
The injections imitate a biological compound to reduce digestion speed, suppress the appetite and enhance the sense of being full so users eat less.
Patients commonly see weight reduction in the initial weeks of starting on the once-weekly jabs.
Studies points to patients may see weight return a year later of discontinuing the treatment, because their normal hunger resume.
To be above a healthy weight raises your chance for experiencing medical conditions, such as diabetes, heart disease, brain attack, and some malignancies.
Obesity concerns individuals in every country and was associated with over three and a half million deaths worldwide in 2024, as per the health agency.
